Retevmo

Made by

• Eli Lilly

Active Ingredient

Selpercatinib

Prospectus

Approval date

2021/9/27

Treats

• Non-small cell lung cancer

Dosages

• レットヴィモカプセル40mg -

• レットヴィモカプセル80mg -